4-(1H-Imidazol-4-ylmethyl)-piperidine manufacturers
- Immepip
-
- $2500.00
-
2026-05-11
- CAS:151070-83-6
- Purity:
- Supply Ability: 10g
|
| | 4-(1H-Imidazol-4-ylmethyl)-piperidine Basic information |
| | 4-(1H-Imidazol-4-ylmethyl)-piperidine Chemical Properties |
| Boiling point | 377.4±22.0 °C(Predicted) | | density | 1.084±0.06 g/cm3(Predicted) | | pka | 14+-.0.10(Predicted) |
| | 4-(1H-Imidazol-4-ylmethyl)-piperidine Usage And Synthesis |
| Uses | Immepip is a H3 agonist. Immepip can reduce cortical histamine release. Immepip can be used for the research of neurological diseases[1]. | | Definition | ChEBI: Immepip is a member of piperidines. | | in vivo | Immepip (i.p.; 5, 10 mg/kg) markedly reduces cortical histamine release, but only weakly promotes sleep in the rat[1]. | Animal Model: | Sprague-Dawley rats[1] | | Dosage: | 5, 10 mg/kg | | Administration: | Intraperitoneally | | Result: | Significantly modulated brain histamine release and slight, albeit significant, decreased in sleep onset latency. |
| | References | [1] Yves Lamberty, et al. H3 agonist immepip markedly reduces cortical histamine release, but only weakly promotes sleep in the rat. Pharmacol Res. 2003 Aug;48(2):193-8. DOI:10.1016/s1043-6618(03)00094-x |
| | 4-(1H-Imidazol-4-ylmethyl)-piperidine Preparation Products And Raw materials |
|